Regeneron Pharma (REGN) PT Lowered to $750 at Cantor Fitzgerald on Negative Eylea Optics
Tweet Send to a Friend
Cantor Fitzgerald analyst Carter Gould lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $750.00 (from $785.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
